A recent Rhazdrugs implementation sparked a valuable discussion about how and why certain drugs end up on hazardous drug lists.
Sherlene Christen
Recent Posts
To Pentamidine or Not to Pentamidine - How A Peer Made this Decision
Topics: Rhazdrugs, Policy, USP <800>, Technology, NIOSH
From 34 to 239: Two Decades of NIOSH Hazardous Drug Lists (And Why the Work Continues)
Remember 2004? Shrek 2 was breaking box office records, we were all singing "Yeah!" by Usher, and Facebook was just getting started. That same year, NIOSH published its first list of hazardous drugs in healthcare settings. It was a sample list of 34 drugs that would (slowly) grow into the list of 236 drugs NIOSH released in 2024.
Topics: Rhazdrugs, Policy, USP <800>, Technology, NIOSH
Breaking Down NIOSH 2024: Antineoplastic Reclassification and Biologic Handling Updates
Is it too late to say Happy New Year? Maybe Happy New NIOSH is more appropriate? 🥳
As you know, by the end of 2024, NIOSH delivered a present we’ve been waiting nearly nine years for. This present comes with a bag of screws and nails and that one tool that never works. In other words, we’re happy to have this guidance but it was not without some serious work to get the benefits.
Topics: Rhazdrugs, Policy, USP <800>, Technology, NIOSH